The struggling genetic testing company 23andMe says it will cut 40% of its workforce, or 200 jobs, as it fights for survival.
23andMe is shutting down its therapeutics development division, and plans to seek out buyers to find a new home for its ...
Holding “announced a business restructuring to streamline operations and reduce costs. In addition, 23andMe is discontinuing ...
23andMe, the genetics startup that has repeatedly captured the public imagination and then faced nearly fatal business ...
Requesting deletion closes your account permanently and prevents your data from being used in further research (existing ...
Reduces workforce by roughly 40%; expects annualized cost savings of more than $35 millionDiscontinues development of therapeutics division and ...
Genetic testing firm 23andMe said on Monday it is reducing about 40 per cent, or 200 employees, from its workforce and ...
Genetic testing firm 23andMe said today it is reducing about 40%, or 200 employees, from its workforce and discontinuing further development of all its therapies as part of a restructuring program. ...
SUNNYVALE, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- An earlier release under the same headline should have noted 23andMe ...